Pharmacy & Pharmaceutical Sciences / Microsomal CYP450 Metabolism
FREE TO EXPLORE
LABORATORY 20 · PHARMACY & PHARMACEUTICAL SCIENCES

Hepatic Microsomal Cytochrome P450 Metabolism: Phase I Intrinsic Clearance of Phenacetin

Quantify the in vitro Phase I O-deethylation velocity and intrinsic hepatic clearance (CLint) of phenacetin catalyzed by CYP1A2 in human liver microsomes (HLM). Explore interactive pharmaceutical simulation, formulation physics, and analytical assays.

PHARMACY & PHARMACEUTICAL SCIENCES · PHARMACEUTICS · ANALYSIS · PHARMACOKINETICS · PHARMACOLOGY

Your virtual pharmacy & pharmaceutical sciences laboratory.

ACETAMINOPHEN METABOLITE FORMATION VELOCITY—
CALIBRATED PHARMACEUTICAL TELEMETRY

Ready to sample with Microsomal Protein = 1.0 mg/mL.

1.0 mg/mL
Standardized USP / Ph. Eur. pharmaceutical testing protocol.

Adjust Microsomal Protein, then execute analytical assay.

Active pharmaceutical ingredient (API) concentration and physicochemical telemetry are recorded using high-precision digital instrumentation and 64-bit IEEE 754 floating-point logging under temperature-controlled laboratory conditions. Residuals reflect ordinary least-squares regression across successive observations. Continuous data structures support comprehensive pharmaceutics, analytical, and pharmacokinetic evaluation.

Pharmaceutical constitutive model and compendial boundary limits

All pharmaceutical assays, dissolution profiles, and pharmacokinetic parameters are evaluated under standardized USP and ICH laboratory protocols. Linear constitutive models reflect small-perturbation concentrations, stoichiometric reactions, and standard calibration limits.

Laboratory apparatus & testing equipment.

Pooled Human Liver Microsomes (HLM, 20 mg/mL, -80 °C storage)

Primary standardized university-grade instrument delivering calibrated, traceable measurements for Microsomal CYP450 Metabolism protocols.

NADPH-Regenerating System (NADP+, G6P, Glucose-6-Phosphate Dehydrogenase)

Essential secondary analytical hardware maintaining environmental, photometric, or mechanical equilibrium during Microsomal CYP450 Metabolism procedures.

Precision Water Bath Shaker Incubator (37.0 ± 0.1 °C)

Specialized sample holding vessel, reaction column, or sensor cell eliminating matrix artifacts.

Refrigerated Micro-Centrifuge (14,000 rpm for protein quenching)

High-precision digital telemetry recording interface capturing 64-bit real-time analytical readings in accordance with pharmacopoeial standards.

HPLC System with UV/Fluorescence Detectors

Analytical reagent grade reference standard or carrier fluid ensuring calibration traceability.

Analytical Micro-Pipettes with Calibration Certificates

Precision measurement tool verifying transducer zero-drift and alignment prior to analytical testing.

FOLLOW THE METHOD

A reason behind every step.

Quantify the in vitro Phase I O-deethylation velocity and intrinsic hepatic clearance (CLint) of phenacetin catalyzed by CYP1A2 in human liver microsomes (HLM). Standardized parameter settings: 0.2, 0.5, 0.9, 1.3, 1.6, 2.0 mg/mL.

  1. Step 1

    Instrument Initialization & Baseline Tare

    Power on the analytical instrumentation for Microsomal CYP450 Metabolism, allow a 30-minute electronic warm-up period, and verify transducer zero-tare using certified standards.

  2. Step 2

    Standard Solution & Matrix Specimen Preparation

    Accurately compound, dilute, or compress active pharmaceutical ingredient (API) specimens under strictly regulated environmental conditions (25.0 ± 0.5 °C).

  3. Step 3

    Systematic Independent Variable Setting

    Adjust the independent testing parameter (Microsomal Protein) across the designated analytical range (0.2 to 2.0 mg/mL) in uniform calibrated steps.

  4. Step 4

    Analytical Signal Acquisition & Telemetry Logging

    Execute the measurement cycle and record steady-state telemetry for Acetaminophen Metabolite Formation Velocity with high-precision digital integration.

  5. Step 5

    Replicate Verification & Equilibrium Inspection

    Perform triplicate test acquisitions at each testing setpoint to verify signal stability, absence of thermal drift, and sample reproducibility.

  6. Step 6

    Regression Modeling & Pharmacopoeial Parameter Derivation

    Plot Microsomal Protein (mg/mL) against Formation Rate (nmol/min), execute ordinary least-squares (OLS) linear regression, and calculate Specific CYP450 Catalytic Activity (m) against compendial benchmarks.

YOUR NOTEBOOK · 0 OBSERVATIONS

Turn measurements into pharmaceutical insight.

See a complete example report ↗

Points are your recorded observations. The solid regression line validates Microsomal CYP450 Metabolism mathematical scaling.

LINEAR REGRESSION FIT · y = mx + b
Formation Rate (nmol/min) = 3.4500 · Protein Conc (mg/mL) + 0.1200
#Human Liver Microsomal Protein Concentration (mg/mL)Acetaminophen Metabolite Formation Velocity (nmol/min)Microsomal Protein (mg/mL)Formation Rate (nmol/min)

No readings yet. Execute an analytical assay and record it.

CHECK YOUR UNDERSTANDING

Explain what the pharmaceutical metrics mean.

Question 1: The primary physicochemical principle investigated in Microsomal CYP450 Metabolism is:

Question 2: In the evaluation of Microsomal CYP450 Metabolism, increasing Microsomal Protein results in:

Question 3: Which regulatory compendium defines official testing specifications for Microsomal CYP450 Metabolism?

Question 4: Ordinary least-squares (OLS) regression in Microsomal CYP450 Metabolism is utilized to:

THEORY AND CLINICAL CONTEXT

Pharmacy & Pharmaceutical Sciences background & chemical principles.

Quantify the in vitro Phase I O-deethylation velocity and intrinsic hepatic clearance (CLint) of phenacetin catalyzed by CYP1A2 in human liver microsomes (HLM).

Formation Rate (nmol/min) = 3.4500 · Protein Conc (mg/mL) + 0.1200

Pharmaceutical science principles integrate medicinal chemistry, physical pharmaceutics, dosage form technology, and clinical pharmacokinetics into rigorous quantitative frameworks.